| Diabetes and complications: cellular signaling pathways, current understanding and targeted therapies K A Adeshara, A G Diwan, R S Tupe Current drug targets 17 (11), 1309-1328, 2016 | 104 | 2016 |
| Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study KA Adeshara, NS Bangar, PR Doshi, A Diwan, RS Tupe Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (5), 1449-1458, 2020 | 41 | 2020 |
| Syzygium jambolanum and Cephalandra indica homeopathic preparations inhibit albumin glycation and protect erythrocytes: an in vitro study RS Tupe, A Kulkarni, K Adeshara, S Shaikh, N Shah, A Jadhav Homeopathy 104 (03), 197-204, 2015 | 37 | 2015 |
| Relationship between plasma glycation with membrane modification, oxidative stress and expression of glucose trasporter-1 in type 2 diabetes patients with vascular complications KA Adeshara, AG Diwan, TR Jagtap, K Advani, A Siddiqui, RS Tupe Journal of Diabetes and its Complications 31 (2), 439-448, 2017 | 29 | 2017 |
| Zinc inhibits glycation induced structural, functional modifications in albumin and protects erythrocytes from glycated albumin toxicity R Tupe, A Kulkarni, K Adeshara, N Sankhe, S Shaikh, S Dalal, S Bhosale, ... International journal of biological macromolecules 79, 601-610, 2015 | 24 | 2015 |
| Antiglycation and cell protective actions of metformin and glipizide in erythrocytes and monocytes K Adeshara, R Tupe Molecular biology reports 43, 195-205, 2016 | 22 | 2016 |
| Plasma glycation adducts and various RAGE isoforms are intricately associated with oxidative stress and inflammatory markers in type 2 diabetes patients with vascular complications KA Adeshara, N Bangar, AG Diwan, RS Tupe Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16 (3), 102441, 2022 | 19 | 2022 |
| Gastrointestinal manifestations after Roux-en-Y gastric bypass surgery in individuals with and without type 2 diabetes MA Härma, K Adeshara, N Istomin, M Lehto, M Blaut, MJ Savolainen, ... Surgery for Obesity and Related Diseases 17 (3), 585-594, 2021 | 19 | 2021 |
| Pioglitazone inhibits advanced glycation induced protein modifications and down-regulates expression of RAGE and NF-κB in renal cells KA Adeshara, SB Agrawal, SM Gaikwad, RS Tupe International journal of biological macromolecules 119, 1154-1163, 2018 | 17 | 2018 |
| Endothelial Dysfunction is Associated With Early‐Onset Cryptogenic Ischemic Stroke in Men and With Increasing Age N Martinez‐Majander, D Gordin, L Joutsi‐Korhonen, T Salopuro, ... Journal of the American Heart Association 10 (14), e020838, 2021 | 10 | 2021 |
| Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease S Wedenoja, A Saarikivi, J Mälkönen, S Leskinen, M Lehto, K Adeshara, ... PloS One 17 (6), e0269561, 2022 | 7 | 2022 |
| Long-chain polyphosphates inhibit type I interferon signaling and augment LPS-induced cytokine secretion in human leukocytes A Pirttiniemi, K Adeshara, N Happonen, E Einarsdottir, S Katayama, ... Journal of Leukocyte Biology 114 (3), 250-265, 2023 | 5 | 2023 |
| Glycemic control is not related to cerebral small vessel disease in neurologically asymptomatic individuals with type 1 diabetes J Inkeri, K Adeshara, V Harjutsalo, C Forsblom, R Liebkind, T Tatlisumak, ... Acta Diabetologica, 1-10, 2022 | 5 | 2022 |
| VEGF/CDK2 are involved in diabetic organ regeneration RK Ambasta, K Adeshara, S Yadav, P Kumar Biochemical and Biophysical Research Communications 529 (4), 1094-1100, 2020 | 5 | 2020 |
| Markers of early vascular aging are not associated with cryptogenic ischemic stroke in the young: A case-control study N Martinez-Majander, D Gordin, L Joutsi-Korhonen, T Salopuro, ... Journal of Stroke and Cerebrovascular Diseases 31 (9), 106647, 2022 | 3 | 2022 |
| Total fecal IgA levels increase and natural IgM antibodies decrease after gastric bypass surgery N Istomin, MA Härma, R Akhi, AE Nissinen, MJ Savolainen, K Adeshara, ... Apmis 130 (11), 637-646, 2022 | 2 | 2022 |
| Protein glycation products associate with progression of kidney disease and incident cardiovascular events in individuals with type 1 diabetes K Adeshara, D Gordin, AA Antikainen, V Harjutsalo, N Sandholm, ... Cardiovascular Diabetology 23 (1), 235, 2024 | 1 | 2024 |
| Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia K Adeshara, E Di Marco, M Bordino, D Gordin, L Bernardi, ME Cooper, ... Cardiovascular Diabetology 23 (1), 350, 2024 | | 2024 |
| 7-OR: Causal Associations between Glyoxalase 1 Expression and Kidney Disease in Type 1 Diabetes K ADESHARA, EH DAHLSTROM, M LEHTO, PERH GROOP, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| IDF23-0032 Soluble receptor for advanced glycation end products and CVD risk in T1D individuals with resistant hypertension K Adeshara, R Lithovius, S Mutter, V Harjutsalo, M Lehto, PH Groop Diabetes Research and Clinical Practice 209, 111132, 2024 | | 2024 |
